1
|
Desmonts C, Lasnon C, Jaudet C, Aide N. PET imaging and quantification of small animals using a clinical SiPM-based camera. EJNMMI Phys 2023; 10:61. [PMID: 37804338 PMCID: PMC10560240 DOI: 10.1186/s40658-023-00583-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 09/29/2023] [Indexed: 10/09/2023] Open
Abstract
BACKGROUND Small-animal PET imaging is an important tool in preclinical oncology. This study evaluated the ability of a clinical SiPM-PET camera to image several rats simultaneously and to perform quantification data analysis. METHODS Intrinsic spatial resolution was measured using 18F line sources, and image quality was assessed using a NEMA NU 4-2018 phantom. Quantification was evaluated using a fillable micro-hollow sphere phantom containing 4 spheres of different sizes (ranging from 3.95 to 7.86 mm). Recovery coefficients were computed for the maximum (Amax) and the mean (A50) pixel values measured on a 50% isocontour drawn on each sphere. Measurements were performed first with the phantom placed in the centre of the field of view and then in the off-centre position with the presence of three scattering sources to simulate the acquisition of four animals simultaneously. Quantification accuracy was finally validated using four 3D-printed phantoms mimicking rats with four subcutaneous tumours each. All experiments were performed for both 18F and 68Ga radionuclides. RESULTS Radial spatial resolutions measured using the PSF reconstruction algorithm were 1.80 mm and 1.78 mm for centred and off-centred acquisitions, respectively. Spill-overs in air and water and uniformity computed with the NEMA phantom centred in the FOV were 0.05, 0.1 and 5.55% for 18F and 0.08, 0.12 and 2.81% for 68Ga, respectively. Recovery coefficients calculated with the 18F-filled micro-hollow sphere phantom for each sphere varied from 0.51 to 1.43 for Amax and from 0.40 to 1.01 for A50. These values decreased from 0.28 to 0.92 for Amax and from 0.22 to 0.66 for A50 for 68 Ga acquisition. The results were not significantly different when imaging phantoms in the off-centre position with 3 scattering sources. Measurements performed with the four 3D-printed phantoms showed a good correlation between theoretical and measured activity in simulated tumours, with r2 values of 0.99 and 0.97 obtained for 18F and 68Ga, respectively. CONCLUSION We found that the clinical SiPM-based PET system was close to that obtained with a dedicated small-animal PET device. This study showed the ability of such a system to image four rats simultaneously and to perform quantification analysis for radionuclides commonly used in oncology.
Collapse
Affiliation(s)
- Cédric Desmonts
- Nuclear Medicine Department, University Hospital of Caen, Avenue de La Côte de Nacre, 14033, Caen Cedex 9, France.
- Normandy University, UNICAEN, INSERM 1086 ANTICIPE, Caen, France.
| | - Charline Lasnon
- Normandy University, UNICAEN, INSERM 1086 ANTICIPE, Caen, France
- Nuclear Medicine Department, UNICANCER, Comprehensive Cancer Centre F. Baclesse, Caen, France
| | - Cyril Jaudet
- Radiophysics Department, UNICANCER, Comprehensive Cancer Centre F. Baclesse, Caen, France
| | - Nicolas Aide
- Normandy University, UNICAEN, INSERM 1086 ANTICIPE, Caen, France
| |
Collapse
|
2
|
Weyts K, Quak E, Licaj I, Ciappuccini R, Lasnon C, Corroyer-Dulmont A, Foucras G, Bardet S, Jaudet C. Deep Learning Denoising Improves and Homogenizes Patient [ 18F]FDG PET Image Quality in Digital PET/CT. Diagnostics (Basel) 2023; 13:diagnostics13091626. [PMID: 37175017 PMCID: PMC10177812 DOI: 10.3390/diagnostics13091626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 04/18/2023] [Accepted: 04/23/2023] [Indexed: 05/15/2023] Open
Abstract
Given the constant pressure to increase patient throughput while respecting radiation protection, global body PET image quality (IQ) is not satisfactory in all patients. We first studied the association between IQ and other variables, in particular body habitus, on a digital PET/CT. Second, to improve and homogenize IQ, we evaluated a deep learning PET denoising solution (Subtle PETTM) using convolutional neural networks. We analysed retrospectively in 113 patients visual IQ (by a 5-point Likert score in two readers) and semi-quantitative IQ (by the coefficient of variation in the liver, CVliv) as well as lesion detection and quantification in native and denoised PET. In native PET, visual and semi-quantitative IQ were lower in patients with larger body habitus (p < 0.0001 for both) and in men vs. women (p ≤ 0.03 for CVliv). After PET denoising, visual IQ scores increased and became more homogeneous between patients (4.8 ± 0.3 in denoised vs. 3.6 ± 0.6 in native PET; p < 0.0001). CVliv were lower in denoised PET than in native PET, 6.9 ± 0.9% vs. 12.2 ± 1.6%; p < 0.0001. The slope calculated by linear regression of CVliv according to weight was significantly lower in denoised than in native PET (p = 0.0002), demonstrating more uniform CVliv. Lesion concordance rate between both PET series was 369/371 (99.5%), with two lesions exclusively detected in native PET. SUVmax and SUVpeak of up to the five most intense native PET lesions per patient were lower in denoised PET (p < 0.001), with an average relative bias of -7.7% and -2.8%, respectively. DL-based PET denoising by Subtle PETTM allowed [18F]FDG PET global image quality to be improved and homogenized, while maintaining satisfactory lesion detection and quantification. DL-based denoising may render body habitus adaptive PET protocols unnecessary, and pave the way for the improvement and homogenization of PET modalities.
Collapse
Affiliation(s)
- Kathleen Weyts
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Elske Quak
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Idlir Licaj
- Department of Biostatistics, Baclesse Cancer Centre, 14076 Caen, France
- Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, 9019 Tromsø, Norway
| | - Renaud Ciappuccini
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Charline Lasnon
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Aurélien Corroyer-Dulmont
- Department of Medical Physics, Baclesse Cancer Centre, 14076 Caen, France
- ISTCT Unit, CNRS, UNICAEN, Normandy University, GIP CYCERON, 14074 Caen, France
| | - Gauthier Foucras
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Stéphane Bardet
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
| | - Cyril Jaudet
- Department of Nuclear Medicine, Baclesse Cancer Centre, 14076 Caen, France
- Department of Medical Physics, Baclesse Cancer Centre, 14076 Caen, France
| |
Collapse
|
3
|
Quak E, Weyts K, Jaudet C, Prigent A, Foucras G, Lasnon C. Artificial intelligence-based 68Ga-DOTATOC PET denoising for optimizing 68Ge/68Ga generator use throughout its lifetime. Front Med (Lausanne) 2023; 10:1137514. [PMID: 36993807 PMCID: PMC10040856 DOI: 10.3389/fmed.2023.1137514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2023] [Accepted: 01/30/2023] [Indexed: 03/14/2023] Open
Abstract
IntroductionThe yield per elution of a 68Ge/68Ga generator decreases during its lifespan. This affects the number of patients injected per elution or the injected dose per patient, thereby negatively affecting the cost of examinations and the quality of PET images due to increased image noise. We aimed to investigate whether AI-based PET denoising can offset this decrease in image quality parameters.MethodsAll patients addressed to our PET unit for a 68Ga-DOTATOC PET/CT from April 2020 to February 2021 were enrolled. Forty-four patients underwent their PET scans according to Protocol_FixedDose (150 MBq) and 32 according to Protocol_WeightDose (1.5 MBq/kg). Protocol_WeightDose examinations were processed using the Subtle PET software (Protocol_WeightDoseAI). Liver and vascular SUV mean were recorded as well as SUVmax, SUVmean and metabolic tumour volume (MTV) of the most intense tumoural lesion and its background SUVmean. Liver and vascular coefficients of variation (CV), tumour-to-background and tumour-to-liver ratios were calculated.ResultsThe mean injected dose of 2.1 (0.4) MBq/kg per patient was significantly higher in the Protocol_FixedDose group as compared to 1.5 (0.1) MBq/kg for the Protocol_WeightDose group. Protocol_WeightDose led to noisier images than Protocol_FixedDose with higher CVs for liver (15.57% ± 4.32 vs. 13.04% ± 3.51, p = 0.018) and blood-pool (28.67% ± 8.65 vs. 22.25% ± 10.37, p = 0.0003). Protocol_WeightDoseAI led to less noisy images than Protocol_WeightDose with lower liver CVs (11.42% ± 3.05 vs. 15.57% ± 4.32, p < 0.0001) and vascular CVs (16.62% ± 6.40 vs. 28.67% ± 8.65, p < 0.0001). Tumour-to-background and tumour-to-liver ratios were lower for protocol_WeightDoseAI: 6.78 ± 3.49 vs. 7.57 ± 4.73 (p = 0.01) and 5.96 ± 5.43 vs. 6.77 ± 6.19 (p < 0.0001), respectively. MTVs were higher after denoising whereas tumour SUVmax were lower: the mean% differences in MTV and SUVmax were + 11.14% (95% CI = 4.84–17.43) and −3.92% (95% CI = −6.25 to −1.59).ConclusionThe degradation of PET image quality due to a reduction in injected dose at the end of the 68Ge/68Ga generator lifespan can be effectively counterbalanced by using AI-based PET denoising.
Collapse
Affiliation(s)
- Elske Quak
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
| | - Kathleen Weyts
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
| | - Cyril Jaudet
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
- Radiophysics Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
| | - Anaïs Prigent
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
- Radiopharmacy Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
| | - Gauthier Foucras
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
- Radiopharmacy Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
| | - Charline Lasnon
- Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France
- UNICAEN, INSERM 1086 ANTICIPE, Normandy University, Caen, France
- *Correspondence: Charline Lasnon, ; orcid.org/0000-0001-5643-1668
| |
Collapse
|
4
|
Doudard A, Corroyer-Dulmont A, Jaudet C, Bernaudin M, Valable S, Ledoux X, Frelin-Labalme AM. Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy. Med Phys 2023. [PMID: 36734667 DOI: 10.1002/mp.16279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 01/16/2023] [Accepted: 01/29/2023] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND The improvement of in vitro assessment of targeted alpha therapy (reproducibility, comparability of experiments…) requires precise evaluation of the dose delivered to the cells. To answer this need, a previous study proposed an innovative dosimetry method based on α-spectroscopy and a specific deconvolution process to recover the spatial distribution of 212 Pb isotopes inside in vitro culture wells. Nevertheless, although promising, the deconvolution method was time consuming and only tested for a simple isotope decay chain. PURPOSE The purpose of this work is to propose a new matrix deconvolution method of α spectra based on a constrained-non-negative-maximum-likelihood decomposition, both faster and offering a greater modelling flexibility, allowing to study independently the kinetics of each of the daughter nuclides of complex decay chains (illustrated here with 223 Ra) in in vitro culture wells. METHODS Firstly, the performance of the new method was fully evaluated through Monte Carlo simulations of in vitro irradiations. Different spatial distributions of 212 Pb and 223 Ra, the corresponding α spectra measured by a silicon detector and the doses delivered to the cells were simulated with Geant4. The deconvolution results were then compared to the simulation results. Secondly, measurements were carried out in culture wells without cells containing 15 kBq of 212 Pb or 9.3 kBq of 223 Ra, placed above silicon detectors recording α spectra in real time. The matrix deconvolution was then applied to determine the spatial and temporal distribution of all α-emitting daughters of studied isotopes. RESULTS The matrix deconvolution was proved to recover the simulated distribution gradients, ensuring simulated doses within 3 % for both tested radionuclides, with errors on dose normally distributed around the reference value (consequently not exhibiting any bias), even in the case of complex decay chains as 223 Ra. The experimental study of 212 Pb and 223 Ra showed highly inhomogeneous distributions and time evolution of the concentration gradients, consistent with the previous study. Furthermore, it highlighted the complex kinetics of 223 Ra with different distributions of its α-emitting daughters (219 Rn, 215 Po, 215 At, 211 Bi, 211 Po). CONCLUSIONS This study validates a new deconvolution method, fast and flexible, that proved to be accurate and reliable. This method allowed to reveal the complexity of isotopes kinetics in in vitro experiments, especially with complex decay chains. Experimental dosimetry, necessary to improve reliability of in vitro studies in targeted alpha therapy, is demonstrated to be feasible with the proposed method.
Collapse
Affiliation(s)
- Alexis Doudard
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF CNRS/IN2P3, Caen, France
| | - Aurélien Corroyer-Dulmont
- Medical Physics Department, CLCC François Baclesse, Caen, France.,Normandie Univ, UNICAEN, CNRS, ISTCT, GIP CYCERON, Caen, France
| | - Cyril Jaudet
- Medical Physics Department, CLCC François Baclesse, Caen, France
| | | | - Samuel Valable
- Normandie Univ, UNICAEN, CNRS, ISTCT, GIP CYCERON, Caen, France
| | - Xavier Ledoux
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF CNRS/IN2P3, Caen, France
| | | |
Collapse
|
5
|
Desmonts C, Aide N, Austins H, Jaudet C, Lasnon C. Feasibility of Imaging Small Animals on a 360° Whole-Body Cadmium Zinc Telluride SPECT Camera: a Phantom Study. Mol Imaging Biol 2022; 24:1018-1027. [PMID: 35835951 DOI: 10.1007/s11307-022-01753-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 06/03/2022] [Accepted: 07/01/2022] [Indexed: 12/29/2022]
Abstract
PURPOSE Single-photon emission computed tomography has found an important place in preclinical cancer research. Nevertheless, the cameras dedicated to small animals are not widely available. The present study aimed to assess the feasibility of imaging small animals by a newly released 360° cadmium zinc telluride camera (VERITON, Spectrum Dynamics, Israel) dedicated to human patients. PROCEDURES A cylindrical phantom containing hot spheres was used to evaluate the intrinsic performance of the camera first without the presence of background activity and then with two contrasts between background and hot spheres (1/4 and 1/10). Acquisitions were repeated with different scan durations (10 and 20 min), two tested radioisotopes (Tc-99 m and I-123), and a set of reconstruction parameters (10 iterations [i] 8 subsets [s], 10i16s, 10i32s). A 3D-printed phantom mimicking a rat with four subcutaneous tumours was then used to test the camera under preclinical conditions. RESULTS The results obtained from the micro-hollow sphere phantom showed that it was possible to visualize spheres with an inner diameter of 3.95 mm without background activity. Moreover, spheres with diameters of 4.95 mm can be seen in the condition of high contrast between background and spheres (1/10) and 7.86 mm with lower contrast (1/4). The rat-sized phantom acquisitions showed that 10- and 8-mm subcutaneous tumours were visible with a good contrast obtained for the two radioisotopes tested in this study. Both Tc-99 m and I-123 measurements demonstrated that a 10-min acquisition reconstructed with an ordered subset expectation maximization algorithm applying 10i32s was optimal to obtain sufficient image quality in terms of noise, resolution, and contrast. CONCLUSION Phantom results showed the ability of the system to detect sub-centimetre lesions for various radioisotopes. It seemed feasible to image small animals using a 360° cadmium zinc telluride gamma camera for preclinical cancer research purposes.
Collapse
Affiliation(s)
- Cedric Desmonts
- Nuclear Medicine Department, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen, Cedex 9, France. .,INSERM U1086 ANTICIPE, Normandy University, UNICAEN, Caen, France.
| | - Nicolas Aide
- Nuclear Medicine Department, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen, Cedex 9, France.,INSERM U1086 ANTICIPE, Normandy University, UNICAEN, Caen, France
| | - Henry Austins
- Biomedical Department, Comprehensive Cancer Center F. Baclesse, UNICANCER, Caen, France
| | - Cyril Jaudet
- Medical Physics Department, Comprehensive Cancer Center F. Baclesse, UNICANCER, Caen, France
| | - Charline Lasnon
- INSERM U1086 ANTICIPE, Normandy University, UNICAEN, Caen, France.,Nuclear Medicine Department, Comprehensive Cancer Center F. Baclesse, UNICANCER, Caen, France
| |
Collapse
|
6
|
Moummad I, Jaudet C, Lechervy A, Valable S, Raboutet C, Soilihi Z, Thariat J, Falzone N, Lacroix J, Batalla A, Corroyer-Dulmont A. The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI. Cancers (Basel) 2021; 14:cancers14010036. [PMID: 35008198 PMCID: PMC8750741 DOI: 10.3390/cancers14010036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Revised: 12/14/2021] [Accepted: 12/18/2021] [Indexed: 01/06/2023] Open
Abstract
Simple Summary Due to the central role of magnetic resonance Imaging (MRI) in the management of patients with cancer, waiting lists exceed clinically relevant delays. For this reason, many research groups and MRI manufacturers develop algorithms as resampling and denoising models to allow faster acquisition time without deterioration in image quality. Whereas these algorithms are available in all new MRI, it is not clear how they will impact image features as well as the validity of statistical model of radiomics which use deep images characteristics to predict treatment outcome. The aim of this study was to develop resampling and denoising deep learning (DL) models and evaluate their impact on radiomics from post-Gd-T1w-MRI brain images with brain metastases. We show that resampling and denoising DL models reconstruct low resolution and noised MRI images acquired quickly into high quality images. While fast acquisition loses most of the radiomic-features and invalidates predictive radiomic models, DL models restore these parameters. Abstract Background: Magnetic resonance imaging (MRI) is predominant in the therapeutic management of cancer patients, unfortunately, patients have to wait a long time to get an appointment for examination. Therefore, new MRI devices include deep-learning (DL) solutions to save acquisition time. However, the impact of these algorithms on intensity and texture parameters has been poorly studied. The aim of this study was to evaluate the impact of resampling and denoising DL models on radiomics. Methods: Resampling and denoising DL model was developed on 14,243 T1 brain images from 1.5T-MRI. Radiomics were extracted from 40 brain metastases from 11 patients (2049 images). A total of 104 texture features of DL images were compared to original images with paired t-test, Pearson correlation and concordance-correlation-coefficient (CCC). Results: When two times shorter image acquisition shows strong disparities with the originals concerning the radiomics, with significant differences and loss of correlation of 79.81% and 48.08%, respectively. Interestingly, DL models restore textures with 46.15% of unstable parameters and 25.96% of low CCC and without difference for the first-order intensity parameters. Conclusions: Resampling and denoising DL models reconstruct low resolution and noised MRI images acquired quickly into high quality images. While fast MRI acquisition loses most of the radiomic features, DL models restore these parameters.
Collapse
Affiliation(s)
- Ilyass Moummad
- Medical Physics Department, CLCC François Baclesse, 14000 Caen, France; (I.M.); (C.J.); (Z.S.); (A.B.)
| | - Cyril Jaudet
- Medical Physics Department, CLCC François Baclesse, 14000 Caen, France; (I.M.); (C.J.); (Z.S.); (A.B.)
| | - Alexis Lechervy
- UMR GREYC, Normandie University, UNICAEN, ENSICAEN, CNRS, 14000 Caen, France;
| | - Samuel Valable
- ISTCT/CERVOxy Group, Normandie University, UNICAEN, CEA, CNRS, 14000 Caen, France;
| | - Charlotte Raboutet
- Radiology Department, CLCC François Baclesse, 14000 Caen, France; (C.R.); (J.L.)
| | - Zamila Soilihi
- Medical Physics Department, CLCC François Baclesse, 14000 Caen, France; (I.M.); (C.J.); (Z.S.); (A.B.)
| | - Juliette Thariat
- Radiotherapy Department, CLCC François Baclesse, 14000 Caen, France;
| | - Nadia Falzone
- GenesisCare Theranostics, Building 1 & 11, The Mill, 41-43 Bourke Road, Alexandria, NSW 2015, Australia;
| | - Joëlle Lacroix
- Radiology Department, CLCC François Baclesse, 14000 Caen, France; (C.R.); (J.L.)
| | - Alain Batalla
- Medical Physics Department, CLCC François Baclesse, 14000 Caen, France; (I.M.); (C.J.); (Z.S.); (A.B.)
| | - Aurélien Corroyer-Dulmont
- Medical Physics Department, CLCC François Baclesse, 14000 Caen, France; (I.M.); (C.J.); (Z.S.); (A.B.)
- ISTCT/CERVOxy Group, Normandie University, UNICAEN, CEA, CNRS, 14000 Caen, France;
- Correspondence:
| |
Collapse
|
7
|
Jaudet C, Weyts K, Lechervy A, Batalla A, Bardet S, Corroyer-Dulmont A. The Impact of Artificial Intelligence CNN Based Denoising on FDG PET Radiomics. Front Oncol 2021; 11:692973. [PMID: 34504782 PMCID: PMC8421788 DOI: 10.3389/fonc.2021.692973] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 07/26/2021] [Indexed: 12/22/2022] Open
Abstract
Background With a constantly increasing number of diagnostic images performed each year, Artificial Intelligence (AI) denoising methods offer an opportunity to respond to the growing demand. However, it may affect information in the image in an unknown manner. This study quantifies the effect of AI-based denoising on FDG PET textural information in comparison to a convolution with a standard gaussian postfilter (EARL1). Methods The study was carried out on 113 patients who underwent a digital FDG PET/CT (VEREOS, Philips Healthcare). 101 FDG avid lesions were segmented semi-automatically by a nuclear medicine physician. VOIs in the liver and lung as reference organs were contoured. PET textural features were extracted with pyradiomics. Texture features from AI denoised and EARL1 versus original PET images were compared with a Concordance Correlation Coefficient (CCC). Features with CCC values ≥ 0.85 threshold were considered concordant. Scatter plots of variable pairs with R2 coefficients of the more relevant features were computed. A Wilcoxon signed rank test to compare the absolute values between AI denoised and original images was performed. Results The ratio of concordant features was 90/104 (86.5%) in AI denoised versus 46/104 (44.2%) with EARL1 denoising. In the reference organs, the concordant ratio for AI and EARL1 denoised images was low, respectively 12/104 (11.5%) and 7/104 (6.7%) in the liver, 26/104 (25%) and 24/104 (23.1%) in the lung. SUVpeak was stable after the application of both algorithms in comparison to SUVmax. Scatter plots of variable pairs showed that AI filtering affected more lower versus high intensity regions unlike EARL1 gaussian post filters, affecting both in a similar way. In lesions, the majority of texture features 79/100 (79%) were significantly (p<0.05) different between AI denoised and original PET images. Conclusions Applying an AI-based denoising on FDG PET images maintains most of the lesion’s texture information in contrast to EARL1-compatible Gaussian filter. Predictive features of a trained model could be thus the same, however with an adapted threshold. Artificial intelligence based denoising in PET is a very promising approach as it adapts the denoising in function of the tissue type, preserving information where it should.
Collapse
Affiliation(s)
- Cyril Jaudet
- Medical Physics Department, CLCC François Baclesse, Caen, France
| | - Kathleen Weyts
- Nuclear Medicine Department, CLCC François Baclesse, Caen, France
| | - Alexis Lechervy
- UMR GREYC, Normandie Univ, UNICAEN, ENSICAEN, CNRS, Caen, France
| | - Alain Batalla
- Medical Physics Department, CLCC François Baclesse, Caen, France
| | - Stéphane Bardet
- Nuclear Medicine Department, CLCC François Baclesse, Caen, France
| | - Aurélien Corroyer-Dulmont
- Medical Physics Department, CLCC François Baclesse, Caen, France.,Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy group, GIP CYCERON, Caen, France
| |
Collapse
|
8
|
Corroyer-Dulmont A, Jaudet C, Frelin AM, Fantin J, Weyts K, Vallis KA, Falzone N, Sibson NR, Chérel M, Kraeber-Bodéré F, Batalla A, Bardet S, Bernaudin M, Valable S. Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice. Front Oncol 2021; 11:714514. [PMID: 34504791 PMCID: PMC8423367 DOI: 10.3389/fonc.2021.714514] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Accepted: 08/03/2021] [Indexed: 11/18/2022] Open
Abstract
Brain metastases (BM) are frequently detected during the follow-up of patients with malignant tumors, particularly in those with advanced disease. Despite a major progress in systemic anti-cancer treatments, the average overall survival of these patients remains limited (6 months from diagnosis). Also, cognitive decline is regularly reported especially in patients treated with whole brain external beam radiotherapy (WBRT), due to the absorbed radiation dose in healthy brain tissue. New targeted therapies, for an earlier and/or more specific treatment of the tumor and its microenvironment, are needed. Radioimmunotherapy (RIT), a combination of a radionuclide to a specific antibody, appears to be a promising tool. Inflammation, which is involved in multiple steps, including the early phase, of BM development is attractive as a relevant target for RIT. This review will focus on the (1) early biomarkers of inflammation in BM pertinent for RIT, (2) state of the art studies on RIT for BM, and (3) the importance of dosimetry to RIT in BM. These two last points will be addressed in comparison to the conventional EBRT treatment, particularly with respect to the balance between tumor control and healthy tissue complications. Finally, because new diagnostic imaging techniques show a potential for the detection of BM at an early stage of the disease, we focus particularly on this therapeutic window.
Collapse
Affiliation(s)
- Aurélien Corroyer-Dulmont
- Medical Physics Department, CLCC François Baclesse, Caen, France
- Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP CYCERON, Caen, France
| | - Cyril Jaudet
- Medical Physics Department, CLCC François Baclesse, Caen, France
| | - Anne-Marie Frelin
- Grand accélérateur National d’Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - Jade Fantin
- Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP CYCERON, Caen, France
| | - Kathleen Weyts
- Nuclear Medicine Department, CLCC François Baclesse, Caen, France
| | - Katherine A. Vallis
- Medical Research Council, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom
| | | | - Nicola R. Sibson
- Medical Research Council, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom
| | - Michel Chérel
- Team 13-Nuclear Oncology, CRCINA, INSERM, CNRS, Nantes University, Nantes, France
| | - Françoise Kraeber-Bodéré
- Team 13-Nuclear Oncology, CRCINA, INSERM, CNRS, Nantes University, Nantes, France
- Nuclear Medicine Department, University Hospital, Nantes, France
| | - Alain Batalla
- Medical Physics Department, CLCC François Baclesse, Caen, France
| | - Stéphane Bardet
- Nuclear Medicine Department, CLCC François Baclesse, Caen, France
| | - Myriam Bernaudin
- Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP CYCERON, Caen, France
| | - Samuel Valable
- Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP CYCERON, Caen, France
| |
Collapse
|
9
|
Quak E, Lasne Cardon A, Ciappuccini R, Lasnon C, Bastit V, Le Henaff V, Lireux B, Foucras G, Jaudet C, Berchi C, Grellard JM, Lequesne J, Clarisse B, Bardet S. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2. BMC Endocr Disord 2021; 21:3. [PMID: 33413316 PMCID: PMC7791717 DOI: 10.1186/s12902-020-00667-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Accepted: 12/14/2020] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND The common endocrine disorder primary hyperparathyroidism (PHPT) can be cured by surgery. Preoperative localization of parathyroid adenoma (PTA) by imaging is a prerequisite for outpatient minimally invasive parathyroidectomy (MIP). Compared to inpatient bilateral cervical exploration (BCE) which is performed if imaging is inconclusive, MIP is superior in terms of cure and complication rates and less costly. The imaging procedure F18-choline (FCH) PET/CT outperforms Tc99m-sestaMIBI (MIBI) SPECT/CT for PTA localization, but it is much costlier. The aim of this study is to identify the most efficient first-line imaging modality for optimal patient care in PHPT without added cost to society. METHODS We will conduct a multicenter open diagnostic intervention randomized phase III trial comparing two diagnostic strategies in patients with PHPT: upfront FCH PET/CT versus MIBI SPECT/CT. The primary endpoint is the proportion of patients in whom the first-line imaging method results in successful MIP and cure. Follow-up including biological tests will be performed 1 and 6 months after surgery. The main secondary endpoint is the social cost of both strategies. Other secondary endpoints are as follows: FCH PET/CT and MIBI SPECT/CT diagnostic performance, performance of surgical procedure and complication rate, FCH PET/CT inter- and intra-observer variability and optimization of FCH PET/CT procedure. Fifty-eight patients will be enrolled and randomized 1:1. DISCUSSION FCH PET/CT is a highly efficient but expensive imaging test for preoperative PTA localization and costs three to four times more than MIBI SPECT/CT. Whether FCH PET/CT improves patient outcomes compared to the reference standard MIBI SPECT/CT is unknown. To justify its added cost, FCH PET/CT-guided parathyroid surgery should lead to improved patient management, resulting in higher cure rates and fewer BCEs and surgical complications. In the previous phase II APACH1 study, we showed that second-line FCH PET/CT led to a cure in 88% of patients with negative or inconclusive MIBI SPECT/CT. BCE could be avoided in 75% of patients and surgical complication rates were low. We therefore hypothesize that upfront FCH PET/CT would improve patient care in PHPT and that the reduction in clinical costs would offset the increase in imaging costs. TRIAL REGISTRATION NCT04040946 , registered August 1, 2019. Protocol version Version 2.1 dated from 2020/04/23.
Collapse
Affiliation(s)
- Elske Quak
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| | - Audrey Lasne Cardon
- Department of Head & Neck Surgery, Centre François Baclesse, F-14000 Caen, France
| | - Renaud Ciappuccini
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
- INSERM 1086 ANTICIPE, F-14000 Caen, France
| | - Charline Lasnon
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
- INSERM 1086 ANTICIPE, F-14000 Caen, France
| | - Vianney Bastit
- Department of Head & Neck Surgery, Centre François Baclesse, F-14000 Caen, France
| | - Véronique Le Henaff
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| | - Barbara Lireux
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| | - Gauthier Foucras
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| | - Cyril Jaudet
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| | - Celia Berchi
- INSERM 1086 ANTICIPE, F-14000 Caen, France
- Normandie Univ, UNICAEN, Caen, France
| | | | - Justine Lequesne
- Clinical Research Department, Centre François Baclesse, F-14000 Caen, France
| | - Bénédicte Clarisse
- Clinical Research Department, Centre François Baclesse, F-14000 Caen, France
| | - Stéphane Bardet
- Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Avenue Général Harris, F-14000, 14076 Caen cedex 5, France
| |
Collapse
|
10
|
Jaudet C, Foucras G, Weyts K, Quak E, Ciappucini R, Lasnon C, Batalla A, Bardet S. 50 Counterbalancing a change of acquisition time with reconstruction parameters on numerical PET. Phys Med 2019. [DOI: 10.1016/j.ejmp.2019.09.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
11
|
Jaudet C, Filleron T, Weyts K, Didierlaurent D, Vallot D, Ouali M, Zerdoud S, Dierickx OL, Caselles O, Courbon F. Gated 18F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility Study. J Nucl Med Technol 2019; 47:227-232. [PMID: 31019044 DOI: 10.2967/jnmt.118.223339] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Accepted: 02/20/2019] [Indexed: 12/25/2022] Open
Abstract
Spirometric gating devices (SGDs) can measure the respiratory signal with high temporal resolution and accuracy. The primary objective of this study was to assess the feasibility and tolerance of a gated lung PET/CT acquisition using an SGD. The secondary objective was to compare the technical quality, accuracy, and interoperability of the SGD with that of a standard respiratory gating device, Real-Time Position Management (RPM), based on measurement of vertical thoracoabdominal displacement. Methods: A prospective phase I monocentric clinical study was performed on patients undergoing 18F-FDG PET/CT for assessment of a solitary lung nodule, staging of lung malignancy, or planning of radiotherapy. After whole-body PET/CT, a centered gated acquisition of both PET and CT was simultaneously obtained with the SGD and RPM during normal breathing. Results: Of the 46 patients who were included, 6 were prematurely excluded (1 because of hyperglycemia and 5 because of distant metastases revealed by whole-body PET/CT, leading to an unjustified extra gated acquisition). No serious adverse events were observed. Of the 40 remaining patients, the gated acquisition was prematurely stopped in 1 patient because of mask discomfort (2.5%; confidence interval [CI], 0.1%-13.2%). This event was considered patient tolerance failure. The SGD generated accurately gated PET/CT images, with more than 95% of the breathing cycle detected and high temporal resolution, in 34 of the 39 patients (87.2%; 95% CI, 60.0%-100.0%) and failed to generate a biologic tumor volume in 1 of 21 patients with increased 18F-FDG uptake (4.8%; 95% CI, 0.1%-26.5%). The quality and accuracy of respiratory signal detection and synchronization were significantly better than those obtained with RPM (P < 0.05). Conclusion: This trial supports the use of an SGD for gated lung PET/CT because of its high patient tolerance and accuracy. Although this technique seems to technically outperform RPM for gated PET/CT, further assessment of its superiority and the clinical benefit is warranted. We believe that this technique could be used as a gold standard to develop innovative approaches to eliminate respiration-induced blurring artifacts.
Collapse
Affiliation(s)
- Cyril Jaudet
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - Thomas Filleron
- Department of Biostatistics, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
| | - Kathleen Weyts
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - David Didierlaurent
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - Delphine Vallot
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - Mounia Ouali
- Department of Biostatistics, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
| | - Slimane Zerdoud
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - O Lawrence Dierickx
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - Olivier Caselles
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| | - Frédéric Courbon
- Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and
| |
Collapse
|
12
|
Dercle L, Ammari S, Bateson M, Durand PB, Haspinger E, Massard C, Jaudet C, Varga A, Deutsch E, Soria JC, Ferté C. Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence. Sci Rep 2017; 7:7952. [PMID: 28801575 PMCID: PMC5554130 DOI: 10.1038/s41598-017-08310-5] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Accepted: 07/10/2017] [Indexed: 01/19/2023] Open
Abstract
Entropy is a promising quantitative imaging biomarker for characterizing cancer imaging phenotype. Entropy has been associated with tumor gene expression, tumor metabolism, tumor stage, patient prognosis, and treatment response. Our hypothesis states that tumor-specific biomarkers such as entropy should be correlated between synchronous metastases. Therefore, a significant proportion of the variance of entropy should be attributed to the malignant process. We analyzed 112 patients with matched/paired synchronous metastases (SM#1 and SM#2) prospectively enrolled in the MOSCATO-01 clinical trial. Imaging features were extracted from Regions Of Interest (ROI) delineated on CT-scan using TexRAD software. We showed that synchronous metastasis entropy was correlated across 5 Spatial Scale Filters: Spearman's Rho ranged between 0.41 and 0.59 (P = 0.0001, Bonferroni correction). Multivariate linear analysis revealed that entropy in SM#1 is significantly associated with (i) primary tumor type; (ii) entropy in SM#2 (same malignant process); (iii) ROI area size; (iv) metastasis site; and (v) entropy in the psoas muscle (reference tissue). Entropy was a logarithmic function of ROI area in normal control tissues (aorta, psoas) and in mathematical models (P < 0.01). We concluded that entropy is a tumor-specific metric only if confounding factors are corrected.
Collapse
Affiliation(s)
- Laurent Dercle
- INSERM U1015, Equipe Labellisée Ligue Nationale Contre le Cancer, Gustave Roussy Cancer Campus, Villejuif, France.
- Département de l'imagerie médicale, Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France.
- Department of Radiology, Columbia University Medical Center, New York, New York, USA.
| | - Samy Ammari
- Département de l'imagerie médicale, Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
| | | | - Paul Blanc Durand
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
| | - Eva Haspinger
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
| | - Christophe Massard
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
| | - Cyril Jaudet
- Department of Radiotherapy, UZ Brussel, Brussels, Belgium
| | - Andrea Varga
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
| | - Eric Deutsch
- Département de radiothérapie, Gustave Roussy Cancer Campus, Université Paris Saclay, F-94805, Villejuif, France
- INSERM U981, Biomarqueurs prédictifs et nouvelles stratégies en oncologie, Université Paris Sud, Gustave Roussy, Villejuif, France
| | - Jean-Charles Soria
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France
- INSERM U981, Biomarqueurs prédictifs et nouvelles stratégies en oncologie, Université Paris Sud, Gustave Roussy, Villejuif, France
- INSERM U1030, Paris Sud University, Gustave Roussy, Villejuif, France
| | - Charles Ferté
- Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France.
- INSERM U981, Biomarqueurs prédictifs et nouvelles stratégies en oncologie, Université Paris Sud, Gustave Roussy, Villejuif, France.
- INSERM U1030, Paris Sud University, Gustave Roussy, Villejuif, France.
| |
Collapse
|
13
|
Girardi A, Gevaert T, Jaudet C, Boussaer M, Burghelea M, Dhont J, Reynders T, Tournel K, De Ridder M. PO-0788: First assessment of Delivery Analysis tool for pre-treatment verification on the new Radixact system. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31225-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Dhont J, Verellen D, Burghelea M, Van Den Begin R, Tournel K, Gevaert T, Engels B, Collen C, Jaudet C, Boussaer M, Reynders T, Storme G, De Ridder M. OC-0484: Variability of breathing-induced tumour motion: 4DCT – a source of misguiding information? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30924-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
15
|
Burghelea M, Verellen D, Dhont J, Hung C, Poels K, Van den Begin R, Boussaer M, Tournel K, Jaudet C, Reynders T, Gevaert T, Simon V, De Ridder M. OC-0439: Treating patients with Dynamic Wave Arc: first clinical experience. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30881-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Burghelea M, Verellen D, Dhont J, Hung C, Gevaert T, Van den Begin R, Collen C, Poels K, Tournel K, Boussaer M, Jaudet C, Reynders T, Simon V, de Ridder M. Treating patients with Dynamic Wave Arc: First clinical experience. Radiother Oncol 2017; 122:347-351. [DOI: 10.1016/j.radonc.2017.01.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 01/02/2017] [Accepted: 01/03/2017] [Indexed: 11/30/2022]
|
17
|
Didierlaurent D, Jaudet C, Ribes S, Batatia H, Dierickx LO, Zerdoud S, Brillouet S, Weyts K, Courbon F, Caselles O. Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT. Med Phys 2014; 41:112503. [DOI: 10.1118/1.4897612] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
|
18
|
Jaudet C, Didierlaurent D, Courbon F, Caselles O. A new respiratory gating device to improve 4D PET/CT. Phys Med 2013. [DOI: 10.1016/j.ejmp.2013.08.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
19
|
Didierlaurent D, Ribes S, Caselles O, Jaudet C, Cazalet JM, Batatia H, Courbon F. A new respiratory gating device to improve 4D PET/CT. Med Phys 2013; 40:032501. [DOI: 10.1118/1.4789487] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
|
20
|
Didierlaurent D, Ribes S, Batatia H, Jaudet C, Dierickx LO, Zerdoud S, Brillouet S, Caselles O, Courbon F. The retrospective binning method improves the consistency of phase binning in respiratory-gated PET/CT. Phys Med Biol 2012; 57:7829-41. [PMID: 23135238 DOI: 10.1088/0031-9155/57/23/7829] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
This study assesses the accuracy of prospective phase-gated PET/CT data binning and presents a retrospective data binning method that improves image quality and consistency. Respiratory signals from 17 patients who underwent 4D PET/CT were analysed to evaluate the reproducibility of temporal triggers used for the standard phase-based gating method. Breathing signals were reprocessed to implement retrospective PET data binning. The mean and standard deviation of time lags between automatic triggers provided by the Real-time Position Management (RPM, Varian) gating device and inhalation peaks derived from respiratory curves were computed for each patient. The total number of respiratory cycles available for 4D PET/CT according to the binning mode (prospective versus retrospective) was compared. The maximum standardized uptake value (SUV(max)), biological tumour volume (BTV) and tumour trajectory measures were determined from the PET/CT images of five patients. Compared to retrospective binning (RB), prospective gating approach led to (i) a significant loss in breathing cycles (15%) and (ii) the inconsistency of data binning due to temporal dispersion of triggers (average 396 ms). Consequently, tumour characterization could be impacted. In retrospective mode, SUV(max) was up to 27% higher, where no significant difference appeared in BTV. In addition, prospective mode gave an inconsistent spatial location of the tumour throughout the bins. Improved consistency with breathing patterns and greater motion amplitude of the tumour centroid were observed with retrospective mode. The detection of the tumour motion and trajectory was improved also for small temporal dispersion of triggers. This study shows that the binning mode could have a significant impact on 4D PET images. The consistency of triggers with breathing signals should be checked before clinical use of gated PET/CT images, and our RB method improves 4D PET/CT image quantification.
Collapse
Affiliation(s)
- D Didierlaurent
- SIMAD, LU 50, Université Paul Sabatier Toulouse III, Toulouse, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Jaudet C, Didierlaurent D, Vallot D, Caselles O, Courbon F. R153: Optimisation en TEP/TDM : contrôle de qualité inter-centre et acquisition synchronisée à la respiration. Bull Cancer 2010. [DOI: 10.1016/s0007-4551(15)31074-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Audouard A, Jaudet C, Vignolles D, Liang R, Bonn DA, Hardy WN, Taillefer L, Proust C. Multiple quantum oscillations in the de Haas-van Alphen spectra of the underdoped high-temperature superconductor YBa2Cu3O6.5. Phys Rev Lett 2009; 103:157003. [PMID: 19905661 DOI: 10.1103/physrevlett.103.157003] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/02/2008] [Indexed: 05/28/2023]
Abstract
By improving the experimental conditions and extensive data accumulation, we have achieved very high precision in the measurements of the de Haas-van Alphen effect in the underdoped high-temperature superconductor YBa2Cu3O6.5. We find that the main oscillation, so far believed to be single frequency, is composed of three closely spaced frequencies. We attribute this to bilayer splitting and warping of a single quasi-2D Fermi surface, indicating that c axis coherence is restored at low temperature in underdoped cuprates. Our results do not support the existence of a larger frequency of the order of 1650 T reported recently in the same compound [S. E. Sebastian, Nature (London) 454, 200 (2008)].
Collapse
Affiliation(s)
- Alain Audouard
- Laboratoire National des Champs Magnétiques Intenses (CNRS), Toulouse, France
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Vignolle B, Carrington A, Cooper RA, French MMJ, Mackenzie AP, Jaudet C, Vignolles D, Proust C, Hussey NE. Quantum oscillations in an overdoped high-Tc superconductor. Nature 2008. [DOI: 10.1038/nature07323] [Citation(s) in RCA: 216] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
24
|
Jaudet C, Vignolles D, Audouard A, Levallois J, LeBoeuf D, Doiron-Leyraud N, Vignolle B, Nardone M, Zitouni A, Liang R, Bonn DA, Hardy WN, Taillefer L, Proust C. de Haas-van Alphen oscillations in the underdoped high-temperature superconductor YBa2Cu3O6.5. Phys Rev Lett 2008; 100:187005. [PMID: 18518412 DOI: 10.1103/physrevlett.100.187005] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/22/2007] [Indexed: 05/26/2023]
Abstract
The de Haas-van Alphen effect was observed in the underdoped cuprate YBa2Cu3O6.5 via a torque technique in pulsed magnetic fields up to 59 T. Above a field of approximately 30 T the magnetization exhibits clear quantum oscillations with a single frequency of 540 T and a cyclotron mass of 1.76 times the free electron mass, in excellent agreement with previously observed Shubnikov-de Haas oscillations. The oscillations obey the standard Lifshitz-Kosevich formula of Fermi-liquid theory. This thermodynamic observation of quantum oscillations confirms the existence of a well-defined, closed, and coherent, Fermi surface in the pseudogap phase of cuprates.
Collapse
Affiliation(s)
- Cyril Jaudet
- Laboratoire National des Champs Magnétiques Pulsés (CNRS-UPS-INSA), Toulouse, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|